Patent 7723055 was granted and assigned to University of Massachusetts on May, 2010 by the United States Patent and Trademark Office.
Described herein are methods and compositions comprising Wnt5a for the diagnosis and treatment of hematopoietic cancers, and methods of identifying therapeutic compounds for the treatment of hematopoietic cancers.